Fig. 2.
Increased expression of EPHX2 mRNA in the neurospheres from iPSC of schizophrenia patients and postmortem brain samples from ASD patients. (A) Gene expression of EPHX2 mRNA in the neurospheres from iPSC from schizophrenia patients with the 22q11.2 deletion was significantly higher than that of healthy controls. Data are shown as mean ± SD (n = 12). *P < 0.05 compared with control group (one-tailed Student t test). (B) Gene expression of EPHX2 mRNA in the BA09 and BA40, but not BA21, from ASD patients was significantly higher than that of controls. Data are shown as mean ± SD; *P < 0.05 and **P < 0.01 compared with control group (one-tailed Student t test).